[go: up one dir, main page]

SE8300495D0 - IMPROVEMENTS IN OR RELATING TO NASAL PHARMACEUTICAL COMPOSITIONS - Google Patents

IMPROVEMENTS IN OR RELATING TO NASAL PHARMACEUTICAL COMPOSITIONS

Info

Publication number
SE8300495D0
SE8300495D0 SE8300495A SE8300495A SE8300495D0 SE 8300495 D0 SE8300495 D0 SE 8300495D0 SE 8300495 A SE8300495 A SE 8300495A SE 8300495 A SE8300495 A SE 8300495A SE 8300495 D0 SE8300495 D0 SE 8300495D0
Authority
SE
Sweden
Prior art keywords
relating
pharmaceutical compositions
nasal pharmaceutical
ciliary function
nasal
Prior art date
Application number
SE8300495A
Other languages
Swedish (sv)
Other versions
SE8300495L (en
SE454402B (en
Inventor
J-R Kiechel
F Acezat-Mispelter
D Plas
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8300495D0 publication Critical patent/SE8300495D0/en
Publication of SE8300495L publication Critical patent/SE8300495L/en
Publication of SE454402B publication Critical patent/SE454402B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

: A nasal pharmaceutical composition incorporates a non-toxic agent which is capable of increasing the ciliary function e.g. caffeine and at least partially antagonising the ciliary function depressant effect of the active agent e.g. dihydroergotamine or any other constituent present in the composition.
SE8300495A 1982-02-01 1983-01-31 NATIONAL ADMINISTRATIVE PHARMACEUTICAL COMPOSITION INCLUDING AN ERGOTPEPTIDALKALOID AND XANTIN SE454402B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (3)

Publication Number Publication Date
SE8300495D0 true SE8300495D0 (en) 1983-01-31
SE8300495L SE8300495L (en) 1983-08-02
SE454402B SE454402B (en) 1988-05-02

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8300495A SE454402B (en) 1982-02-01 1983-01-31 NATIONAL ADMINISTRATIVE PHARMACEUTICAL COMPOSITION INCLUDING AN ERGOTPEPTIDALKALOID AND XANTIN

Country Status (27)

Country Link
JP (1) JPS58134017A (en)
AT (1) AT385656B (en)
AU (1) AU565613B2 (en)
BE (1) BE895750A (en)
CA (1) CA1197783A (en)
CH (1) CH653555A5 (en)
DE (1) DE3302949A1 (en)
DK (1) DK164771C (en)
ES (1) ES8502865A1 (en)
FI (1) FI81258C (en)
FR (1) FR2539994B1 (en)
GR (1) GR81320B (en)
HK (1) HK59989A (en)
HU (1) HU191512B (en)
IE (1) IE54532B1 (en)
IL (1) IL67822A (en)
IT (1) IT1197558B (en)
KE (1) KE3888A (en)
LU (1) LU84613A1 (en)
MY (1) MY8700766A (en)
NL (1) NL192325C (en)
NZ (1) NZ203117A (en)
PH (1) PH22198A (en)
PT (1) PT76166B (en)
SE (1) SE454402B (en)
SG (1) SG34389G (en)
ZA (1) ZA83673B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
KR20200118032A (en) * 2018-01-05 2020-10-14 임펠 뉴로파마 인코포레이티드 Intranasal delivery of dihydroergotamine by precise olfactory organ device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (en) * 1976-11-19 1978-06-01 Sandoz Ag NEW FORMS OF ADMINISTRATION FOR ORGANIC COMPOUNDS
FR2387035A1 (en) * 1977-04-12 1978-11-10 Cassenne Lab Sa NEW MEDICINAL PRODUCT INTENDED IN PARTICULAR FOR THE TREATMENT OF FUNCTIONAL CEREBRAL DISORDERS
DE2831728C2 (en) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Medicines used to treat headaches

Also Published As

Publication number Publication date
SE8300495L (en) 1983-08-02
ES519450A0 (en) 1985-02-01
ATA30383A (en) 1987-10-15
DK164771C (en) 1992-12-28
AU565613B2 (en) 1987-09-24
SE454402B (en) 1988-05-02
FI830245A0 (en) 1983-01-25
HU191512B (en) 1987-02-27
AT385656B (en) 1988-05-10
DE3302949A1 (en) 1983-08-11
CH653555A5 (en) 1986-01-15
FI830245L (en) 1983-08-02
ES8502865A1 (en) 1985-02-01
FR2539994A1 (en) 1984-08-03
AU1085083A (en) 1983-08-11
IE54532B1 (en) 1989-11-08
IT8347646A1 (en) 1984-08-01
DE3302949C2 (en) 1992-05-21
MY8700766A (en) 1987-12-31
IL67822A0 (en) 1983-06-15
PH22198A (en) 1988-06-28
LU84613A1 (en) 1983-09-08
HK59989A (en) 1989-08-04
SG34389G (en) 1989-09-22
FR2539994B1 (en) 1986-10-10
DK164771B (en) 1992-08-17
BE895750A (en) 1983-08-01
JPH0253406B2 (en) 1990-11-16
IE830187L (en) 1983-08-01
FI81258C (en) 1990-10-10
DK38183A (en) 1983-08-02
FI81258B (en) 1990-06-29
IT1197558B (en) 1988-12-06
PT76166A (en) 1983-02-01
IL67822A (en) 1988-02-29
NZ203117A (en) 1986-12-05
NL8300325A (en) 1983-09-01
CA1197783A (en) 1985-12-10
GR81320B (en) 1984-12-11
NL192325C (en) 1997-06-04
IT8347646A0 (en) 1983-02-01
ZA83673B (en) 1984-09-26
PT76166B (en) 1986-02-04
JPS58134017A (en) 1983-08-10
DK38183D0 (en) 1983-01-31
KE3888A (en) 1989-09-01
NL192325B (en) 1997-02-03

Similar Documents

Publication Publication Date Title
DE3484997D1 (en) CELL-stimulating agent.
NZ186965A (en) Guanidino derivatives and pharmaceutical compositions
NZ195517A (en) Imidazole-5-acetic acid derivatives and pharmaceutical compositions
DK169683D0 (en) FOOT CARE AGENT
SE9700135D0 (en) New formulation
JPS54160353A (en) Novel phenoxyalkylcarboxylic derivative or its salt and sedative or antiiinflammatory agent containing them as active ingredient
DE3872635D1 (en) PENTAMIDINE CONTAINING PHARMACEUTICAL COMPOSITIONS.
LV10954A (en) Derivatives of benzimidazole as a result of their acquisition and their pharmaceutical composition
PT76314A (en) Process for the preparation of biologically active polysaccharide concentrates and of pharmaceutical and cosmetic compositions containing them
PH13921A (en) Pharmacologically active pyrimidine derivatives and compositions thereof
DE2963646D1 (en) Undecapeptide and its acid addition salts and pharmaceutical compositions
IE781032L (en) Pharmaceutical compositions
ZA812088B (en) Derivative of saccharide and physiologically active agent containing the same
SE8504976L (en) OGONDROPAR CONTAINS BROMOCRIPTIN
IL78061A (en) Pharmaceutical compositions based on simethicone and guar gum for protection of the oesogastroduodenal mucous membrane
JPS55111494A (en) Monophosphonate compound* its manufacture and therapeutic composition containing same as active ingredient
JPS565465A (en) Benzimidazole derivative* its manufacture and medicinal composition of same as active component
NZ184766A (en) Alkylphenyl ethers and thioethers and pharmaceutical compositions
SE8300495D0 (en) IMPROVEMENTS IN OR RELATING TO NASAL PHARMACEUTICAL COMPOSITIONS
ZA773979B (en) Pharmaceutically active benzamine compounds and compositions
IT7825483A0 (en) DERIVATIVES OF CROTONIC ACID PHENOXYPHENOXY AND HERBICIDE COMPOSITION.
IT1106299B (en) 5-IMMINODAUNOMICINA AND ITS DERIVATIVES PROCEDURE TO PREPARE IT AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT
GB2021409A (en) Pharmaceutical composition
NZ191006A (en) Pyrimidine derivatives of isoureas and isothioureas pharmaceutical compositions
NZ184102A (en) Derivatives of benzenesulphonylurea,and pharmaceutical compositions

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8300495-2

Format of ref document f/p: F

NUG Patent has lapsed